Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Povinelli D., Vonk J. (2003): Chimpanzee minds: suspiciously human?,
Trends in Cognitive Sciences 7(4): 157–160.
Powell B.C. et al. (1994): Transgenic sheep and wool growth: possibilities and
current status, Reproductive Fertility Developments 6: 615–623.
Pruszak J., Isacson O. (2009): Molecular and cellular determinants for generating
ES-cell derived dopamine neurons for cell therapy,
Advanced Experimental Medical Biology 651:112–23.
Pursel V.G. et al. (1999): Expression of insulin-like growth factor-I in sceletal
muscle of transgenic swine. In: Murray, J.D., Anderson, G.B., Oberbauer, A.M.,
McGloughlin, M.M. (eds.): Transgenic animals in agriculture.
CAB International: 141.
Pursel V.G. et al. (1989): Genetic engineering of livestock.
Science (Washington D.C.) 244:1281–1288.
Pursel V.G., Mitchell A.D., Bee G. et al. (2004): Growth and tissue accretion
rates of swine expressing an insulin–like growth factor I transgene,
Animal Biotechnology 15: 33–45.
Qiu L. (2006): Mighty Mouse, Nature 444: 814–816.
Ramaswamy S., McBride J.L., Kordower J.H. (2007): Animal Models of
Huntington’s Disease, ILAR Journal 48(4): 356–373.
Rathbone M., Brayden D. (2009): Controlled release drug delivery in farmed
animals: commercial challenges and academic opportunities, Current Drug
Delivery 6(4): 383–90.
Redwan R.M. (2009): Animal-derived pharmaceutical proteins,
Journal of Immunoassay & Immunochemistry 30(3): 262–90.
Rees M.A. (2003): Immunological Effects of Hepativ Xenoperfusion.
University of Cambridge: Cambridge.
Reh W.A., Maga E.A., Collette N.M. et al. (2004): Hot topic: using a
stearoyl-CoA desaturase transgene to alter milk fatty acid composition,
Journal of Dairy Science 87: 3510–3514.
Rehbinder M. et al. (Hg.) (2009): Pharming. Promises and risks of
biopharmaceuticals derived from genetically modified plants and animals.
Europäische Akademie zur Erforschung von Folgen wissenschaftlich-
technischer Entwicklung. Springer: Berlin, Heidelberg.
Reine N.J. (2007) Medical management of pituitary-dependent hyperadre-
nocorticism: mitotane versus trilostane,
Clinical techniques in small animal practice 22(1): 18–25.
Rembold M., Lahiri K., Foulkes N.S., Wittbrodt J. (2006): Transgenesis in fish:
efficient selection of transgenic fish by co-injection with a fluorescent reporter
construct, Nature Protocols 1(3): 1133–9.
Repantis D. et al. (2009): Antidepressants for Neuroenhancement in Healthy
Individuals: A Systematic Review, Poiesis & Praxis: International Journal of
Technology Assessment and Ethics of Science 6(3 – 4): 139 – 174.
Reuter K. (2007): Tierzucht für den ökologischen Landbau – Probleme, offene
Fragen, Lösungsansätze, Tierzucht für den Ökologischen Landbau. Anforderungen,
Ergebnisse, Perspektiven. Dokumentation der Tagung des Netzwerks
Ökologische Tierzucht am 7. und 8. März 2007 in Kassel, Zukunftsstiftung
Landwirtschaft, Bochum: 8–10, http://orgprints.org/15131/1/reuter-etal-2007-
Tagungsband_Tierzucht_Kassel.pdf (zuletzt aufgerufen am 23/07/10).
Revermann C., Hennen L. (2001): Das maßgeschneiderte Tier. Klonen in
Biomedizin und Tierzucht (Studien des Büros für Technikfolgen-Abschätzung
beim Deutschen Bundestag 9), Berlin: edition sigma.
Richt J.A., Kasinathan, P., Hamir, A.N., Castilla, J. et al. (2007): Production of
cattle lacking prion protein. Nature Biotechnology 25: 132–138.
Richter S.H. et al. (2009): Environmental standardization: cure or cause of
poor reproducibility in animal experiments?, Nature Methods 6, 4: 257–261.
212 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
213